Boeing is evaluating Viasat's new AERA electronically steered antenna for potential use across its commercial aircraft programs, which could make it a selectable line-fit option for airlines. The AERA system is designed to provide more consistent in-flight connectivity through multibeam technology and offers benefits like lightweight design, reduced maintenance, and software upgradeability. Viasat shares jumped in premarket trading following the announcement, reflecting strong market confidence and the company's impressive 12-month performance.

Dow has appointed Karen Carter, its operations chief and a long-time insider, as the new CEO, effective July 1. She replaces Jim Fitterling, who will transition to an executive chair role. Carter takes the helm as Dow navigates weak demand, ongoing restructuring efforts, and a global portfolio overhaul, following a period where the company announced 4,500 job cuts and a strategic review of European assets.

The Bank of New York Mellon Corporation (NYSE: BK) is set to release its first-quarter earnings on April 16, with analysts expecting $1.93 per share and $5.19 billion in revenue. Several top analysts have recently revised their ratings and price targets for BNY Mellon, with opinions ranging from Overweight to Equal-Weight and Neutral ratings. The company's shares closed at $129.15 on Monday, following a recent public offering of depositary shares.

Ra Capital Management, L.P., a major shareholder in Adicet Bio (NASDAQ:ACET), recently increased its stake by purchasing 74,268 shares for $535,472.28 at an average cost of $7.21 per share. This transaction, occurring on February 19th, increased their total holdings to 1,107,873 shares, representing a 7.19% increase in their position. Other recent purchases by Ra Capital Management in February include 74,751 shares at $7.27 and 74,577 shares at $7.04.

The Rosen Law Firm is investigating potential securities claims against zSpace Inc. (NASDAQ: ZSPC) for allegedly issuing misleading business information, which could lead to a class action lawsuit to recover investor losses. The firm emphasizes the importance of transparency from public companies and encourages affected investors to join the prospective lawsuit. This investigation highlights the financial and reputational consequences for companies found to have provided inaccurate information.

Dow Inc. has named a 30-year veteran as its new CEO. The company's headquarters are located in Midland. This announcement was made by Crain's Detroit Business on April 14, 2026.

CarMax reported a fourth-quarter loss due to a goodwill impairment charge and declining margins from used vehicles, causing its shares to fall. The used-car sector is struggling with softening consumer demand, leading to reduced retail and wholesale gross profits per vehicle as CarMax cuts prices to stimulate demand. CEO Keith Barr announced urgent actions to improve efficiency and regain sales momentum, while the company also noted a non-cash goodwill impairment charge of $141.3 million, attributing it to a fall in share price and weaker financial performance.

Apellis Pharmaceuticals' board of directors has unanimously recommended stockholders accept Biogen's tender offer to acquire all outstanding common shares for $41.00 per share in cash, plus a contingent value right (CVR) that can pay up to an additional $4.00 per share based on SYFOVRE® net sales milestones. Key figures include 128 million shares outstanding and an estimated $49.1 million golden parachute for CEO Cedric Francois. The acquisition will be structured as a tender offer, followed by a Section 251(h) merger, with the offer set to expire on May 13, 2026.

CarMax Inc. shares tumbled in premarket trading after the company announced an expected continued decline in profit per vehicle sold to retail customers. The used car retailer also expanded its cost-cutting targets as it faces market challenges. Despite a 27% rise year-to-date, the stock remains significantly down over the past five years.

Ramsay Stattman Vela & Price Inc. significantly reduced its stake in Roper Technologies, Inc. (NASDAQ:ROP) by 61.3% in Q4, selling 3,179 shares and retaining 2,011 shares valued at $895,000. Despite this, Roper's director Thomas Patrick Joyce, Jr. acquired 1,400 shares, and institutional investors collectively own 93.31% of the stock. Analysts have a consensus "Hold" rating with an average target price of $476.60, as the company reported an EPS beat and provided FY2026 guidance.